+23.8%
U vs MRNA
+715.3%
-691.4%
-65.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.6% | +1.3% | -5.9% | -4.6% |
| 7D | -6.9% | -13.8% | +6.9% | -6.6% |
| 30D | +16.3% | -17.7% | +33.9% | +16.6% |
| 3M | -0.9% | +14.3% | -15.2% | -1.4% |
| 6M | +78.2% | +336.0% | -257.7% | +61.6% |
| YTD | +5.7% | +575.9% | -570.2% | -10.5% |
| All | +23.8% | +715.3% | -691.4% | -1.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling